Opthea Limited (ASX:OPT)
Australia · Delayed Price · Currency is AUD 0.6000
0.00 (0.00%)
Mar 14, 2025, 4:10 PM AEST
Opthea Market Cap
Opthea has a market cap or net worth of 20.52 million as of July 6, 2026. Its market cap has decreased by -95.87% in one year.
Market Cap
20.52M
Enterprise Value
-12.65M
Revenue
-20.12K
Ranking
n/a
PE Ratio
0.06
Stock Price
0.60
Market Cap Chart
Since May 13, 1996, Opthea's market cap has decreased from 39.30M to 20.52M, a decrease of -47.79%. That is a compound annual growth rate of -2.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 20.52M | -97.94% |
| Dec 31, 2024 | 997.31M | 163.98% |
| Dec 29, 2023 | 377.80M | -11.57% |
| Dec 30, 2022 | 427.23M | -6.26% |
| Dec 31, 2021 | 455.76M | -29.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Proteomics International Laboratories | 33.04M |
| Noxopharm | 28.88M |
| Algorae Pharmaceuticals | 26.33M |
| Patrys | 26.00M |
| Neurotech International | 22.40M |
| EZZ Life Science Holdings | 22.36M |
| NeuroScientific Biopharmaceuticals | 21.28M |
| Argenica Therapeutics | 15.41M |